CHA2DS2-VASc Score in Predicting Visual Acuity Outcomes Following Retinal Vein Occlusion.

IF 1.8 4区 医学 Q3 OPHTHALMOLOGY
Journal of Ophthalmology Pub Date : 2024-10-21 eCollection Date: 2024-01-01 DOI:10.1155/2024/3054783
Achia Nemet, Raimo Tuuminen, Tzadok Yona, Gilad Plopsky, Michal Katz, Natali Glinkin, Olga Lelchuk, Joseph Pikkel
{"title":"CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Predicting Visual Acuity Outcomes Following Retinal Vein Occlusion.","authors":"Achia Nemet, Raimo Tuuminen, Tzadok Yona, Gilad Plopsky, Michal Katz, Natali Glinkin, Olga Lelchuk, Joseph Pikkel","doi":"10.1155/2024/3054783","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> To find whether the CHA<sub>2</sub>DS<sub>2</sub>-VASc score, a system for stratifying stroke risk among patients with atrial fibrillation, correlates with visual acuity prognosis following retinal vein occlusion (RVO). <b>Participants and Methods:</b> This retrospective study included 83 eyes of 83 patients with a diagnosis of branch or central RVO between June 2017 and August 2022 with at least 12 months of follow-up in Assuta Ashdod Medical Center, Ashdod, Israel. The patients were divided into three groups, with CHA<sub>2</sub>DS<sub>2</sub>-VASc scores of 0-2 (<i>N</i> = 31), 3-5 (<i>N</i> = 45), or 6-9 (<i>N</i> = 7). The change in best-corrected visual acuity (BCVA) between the groups was examined about 1 year after the presentation of RVO. <b>Results:</b> The patient mean age was 67.9 ± 13.8 years; 38.6% were women. The mean visual acuity was 0.83 ± 0.67 LogMAR units at the first admission and 0.78 ± 0.80 LogMAR units at the last visit. Patients with a CHA<sub>2</sub>DS<sub>2</sub>-VASc score from 6 to 9 had a significantly poorer BCVA prognosis at 1-year (+0.60 ± 0.94 [-0.27, 1.47] LogMAR units) compared to groups with a CHA<sub>2</sub>DS<sub>2</sub>-VASc score from 3 to 5 (-0.01 ± 0.65 [-0.20, 0.19] LogMAR units) and a CHA<sub>2</sub>DS<sub>2</sub>-VASc score from 0 to 2 (-0.12 ± 0.59 [-0.33, 0.10] LogMAR units) (<i>p</i> = 0.038). <b>Conclusions:</b> Following RVO, patients with a CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 6 or higher had a worse prognosis in their visual acuity than patients with a lower score.</p>","PeriodicalId":16674,"journal":{"name":"Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519066/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2024/3054783","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To find whether the CHA2DS2-VASc score, a system for stratifying stroke risk among patients with atrial fibrillation, correlates with visual acuity prognosis following retinal vein occlusion (RVO). Participants and Methods: This retrospective study included 83 eyes of 83 patients with a diagnosis of branch or central RVO between June 2017 and August 2022 with at least 12 months of follow-up in Assuta Ashdod Medical Center, Ashdod, Israel. The patients were divided into three groups, with CHA2DS2-VASc scores of 0-2 (N = 31), 3-5 (N = 45), or 6-9 (N = 7). The change in best-corrected visual acuity (BCVA) between the groups was examined about 1 year after the presentation of RVO. Results: The patient mean age was 67.9 ± 13.8 years; 38.6% were women. The mean visual acuity was 0.83 ± 0.67 LogMAR units at the first admission and 0.78 ± 0.80 LogMAR units at the last visit. Patients with a CHA2DS2-VASc score from 6 to 9 had a significantly poorer BCVA prognosis at 1-year (+0.60 ± 0.94 [-0.27, 1.47] LogMAR units) compared to groups with a CHA2DS2-VASc score from 3 to 5 (-0.01 ± 0.65 [-0.20, 0.19] LogMAR units) and a CHA2DS2-VASc score from 0 to 2 (-0.12 ± 0.59 [-0.33, 0.10] LogMAR units) (p = 0.038). Conclusions: Following RVO, patients with a CHA2DS2-VASc score of 6 or higher had a worse prognosis in their visual acuity than patients with a lower score.

预测视网膜静脉闭塞后视力结果的 CHA2DS2-VASc 评分
目的:探讨 CHA2DS2-VASc 评分(心房颤动患者卒中风险分层系统)是否与视网膜静脉闭塞 (RVO) 后的视力预后相关。参与者和方法:这项回顾性研究纳入了以色列阿什杜德 Assuta 阿什杜德医疗中心 2017 年 6 月至 2022 年 8 月期间确诊为分支型或中心型 RVO 且随访至少 12 个月的 83 名患者的 83 只眼睛。患者分为三组,CHA2DS2-VASc评分分别为0-2分(31人)、3-5分(45人)或6-9分(7人)。在出现 RVO 约 1 年后,对各组间最佳矫正视力 (BCVA) 的变化进行了检查。结果:患者平均年龄为 67.9 ± 13.8 岁,38.6% 为女性。首次入院时的平均视力为 0.83 ± 0.67 LogMAR 单位,最后一次就诊时的平均视力为 0.78 ± 0.80 LogMAR 单位。与 CHA2DS2-VASc 评分为 3-5 分的患者相比,CHA2DS2-VASc 评分为 6-9 分的患者 1 年后的 BCVA 预后明显较差(+0.60 ± 0.94 [-0.27, 1.47] LogMAR 单位)(-0.01 ± 0.65 [-0.20, 0.19] LogMAR单位)和CHA2DS2-VASc评分为0至2(-0.12 ± 0.59 [-0.33, 0.10] LogMAR单位)的组相比(P = 0.038)。结论RVO后,CHA2DS2-VASc评分为6分或以上的患者视力预后比评分较低的患者差。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Ophthalmology
Journal of Ophthalmology MEDICINE, RESEARCH & EXPERIMENTAL-OPHTHALMOLOGY
CiteScore
4.30
自引率
5.30%
发文量
194
审稿时长
6-12 weeks
期刊介绍: Journal of Ophthalmology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the anatomy, physiology and diseases of the eye. Submissions should focus on new diagnostic and surgical techniques, instrument and therapy updates, as well as clinical trials and research findings.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信